HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism

Cardiovascular Research

Volumn 99, Issue 4, 2013, Pages 674-684

  Li, Jingjin ^a   Zhang, Yangyang ^a   Li, Chuanfu ^b   Xie, Jian ^a   Liu, Ying ^a   Zhu, Weina ^a   Zhang, Xiaojin ^a   Jiang, Surong ^a   Liu, Li ^a   Ding, Zhengnian ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b East Tennessee State University   (United States)

Author keywords

Cardiac dysfunction; Cardiac remodelling; Endothelial NOS (eNOS); Heat shock protein A12B (HSPA12B); Myocardial infarction

Indexed keywords

ANGIOTENSIN I; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN; HSPA12B PROTEIN; N(G) NITROARGININE METHYL ESTER; PROTEIN BCL 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; CAPILLARY DENSITY; CARDIAC REMODELLING; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENDOTOXEMIA; HEART CYCLE; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PAPILLARY MUSCLE; HEART PROTECTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIGHTING REFLEX; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

CARDIAC DYSFUNCTION; CARDIAC REMODELLING; ENDOTHELIAL NOS (ENOS); HEAT SHOCK PROTEIN A12B (HSPA12B); MYOCARDIAL INFARCTION;

ANIMALS; APOPTOSIS; FIBROSIS; HEART; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEINS C-BCL-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

EID: 84883255126     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt139     Document Type: Article

References (38)

1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-2018.
2. Ueda K, Takano H, Niitsuma Y, Hasegawa H, Uchiyama R, Oka T et al. Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice. J Clin Invest 2010;120:2016-2029.
3. Han Z, TruongQA, Park S, BreslowJL.TwoHsp70 familymembers expressed in atherosclerotic lesions. Proc Natl Acad Sci USA 2003;100:1256-1261.
4. Steagall RJ, Rusiñol AE, Truong QA, Han Z. HSPA12B is predominantly expressed in endothelial cells and required for angiogenesis. Arterioscler Thromb Vasc Biol 2006;26: 2012-2018.
5. Hu G, Tang J, Zhang B, Lin Y, Hanai J, Galloway J et al. A novel endothelial-specific heat shock protein HspA12B is required in both zebrafish development and endothelial functions in vitro. J Cell Sci 2006;119:4117-4126.
6. Zhou H, Qian J, Li C, Li J, Zhang X, Ding Z et al. Attenuation of cardiac dysfunction by HSPA12B in endotoxin-induced sepsis in mice through a PI3K-dependent mechanism. Cardiovasc Res 2011;89:109-118.
7. Ma Y, Lu C, Li C, Li R, Zhang Y, MaHet al. Overexpression of HSPA12B protects against cerebral ischemia/reperfusion injury via a PI3 K/Akt-dependent mechanism. Biochim Biophys Acta 2013;1832:57-66.
8. Lavu M, Gundewar S, Lefer DJ. Gene therapy for ischemic heart disease. J Mol Cell Cardiol 2011;50:742-750.
9. Smith RS Jr, Agata J, XiaCF,Chao L, Chao J.Humanendothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 2005;76:2457-2471.
10. Sobajima M, Nozawa T, Shida T, Ohori T, Suzuki T, Matsuki A et al. Repeated sauna therapy attenuates ventricular remodeling after myocardial infarction in rats by increasing coronary vascularity of noninfarcted myocardium. Am J Physiol Heart Circ Physiol 2011; 301:H548-H554.
11. NambaT, Koike H, Murakami K, Aoki M, Makino H, HashiyaNet al. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation 2003;108:2250-2257.
12. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998;101: 2567-2578.
13. Razavi HM, Hamilton JA, Feng Q. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther 2005;106:147-162.
14. Zhang J, Cai H. Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism. J Mol Cell Cardiol 2010;8:1060-1070.
15. deWaard MC, van Haperen R, Soullié T, Tempel D, de Crom R, Duncker DJ. Beneficial effects of exercise training after myocardial infarction require fulleNOSexpression. J Mol Cell Cardiol 2010;48:1041-1049.
16. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997;35:2-4.
17. Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 2008;80:40-46.
18. McSweeney SJ, HadokePW, Kozak AM, Small GR, Khaled H,Walker BR et al. Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11betaHSD1-deficient mice post-MI. Cardiovasc Res 2010;88:159-167.
19. Xu Y, Arenas IA, Armstrong SJ, Plahta WC, Xu H, Davidge ST. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res 2006;69:836-844.
20. Fukumoto T, Yamashita N, Tawa M, Ohkita M, Matsumura Y. Sex differences in postischemic cardiac dysfunction and norepinephrine overflow in rat heart: the role of estrogen against myocardial ischemia-reperfusion damage via an NO-mediated mechanism. J Cardiovasc Pharmacol 2012;60:269-275.
21. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R et al. Inhibition of Rhokinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 2004;24:1842-1847.
22. Baum O, Da Silva-Azevedo L, Willerding G, Wö ckel A, Planitzer G, Gossrau R et al. Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration. Am J Physiol Heart Circ Physiol 2004;287: H2300-H2308.
23. Ha T, Hua F, Liu X, Ma J, McMullen JR, Shioi T et al. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3 K/Akt-dependent mechanism. Cardiovasc Res 2008;78:546-553.
24. Liu L, Zhang X, Qian B, Min X,GaoX, LiCet al. Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice. Eur J Heart Fail 2007;9: 762-769.
25. Chatterjee S, Stewart AS, Bish LT, Jayasankar V, Kim EM, Pirolli T et al. Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure. Circulation 2002;106:I212-I217.
26. Chandrashekhar Y, Sen S, Anway R, Shuros A, Anand I. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 2004;43:295-301.
27. Rosinberg A, Khan TA, Sellke FW, Laham RJ. Therapeutic angiogenesis for myocardial ischemia. Expert Rev Cardiovasc Ther 2004;2:271-283.
28. Ahn A, Frishman WH, Gutwein A, Passeri J, Nelson M. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease-part I. Cardiol Rev 2008;16:163-171.
29. Tao Z, Chen B, Tan X, Zhao Y, Wang L, Zhu T et al. Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci USA 2011; 108:2064-2069.
30. Shimazu T, Otani H, Yoshioka K, Fujita M, Okazaki T, Iwasaka T. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction. Am J Physiol Heart Circ Physiol 2011;301:H2061-H2072.
31. Suzuki K, SawaY, Kaneda Y, Ichikawa H, Shirakura R, Matsuda H. In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemia-reperfusion injury in rat. J Clin Invest 1997;99:1645-1650.
32. FanGC, RenX, Qian J, Yuan Q, Nicolaou P,WangYet al.Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury. Circulation 2005; 111:1792-1799.
33. Prech M, Marszaek A, Schröder J, Filas V, Lesiak M, Jemielity M et al. Apoptosis as a mechanism for the elimination of cardiomyocytes after acute myocardial infarction. Am J Cardiol 2010;105:1240-1245.
34. Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, Feroce F et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 2003;41:753-760.
35. Santini D, Abbate A, Scarpa S, Vasaturo F, Biondi-Zoccai GG, Bussani R et al. Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction. J Clin Pathol 2004;57:1321-324.
36. Adluri RS, Thirunavukkarasu M, Zhan L, Akita Y, Samuel SM, OtaniHet al. Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice. J Mol Cell Cardiol 2011;50:239-247.
37. Lee SH,Wolf PL, Escudero R, Deutsch R, JamiesonSW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000;342:626-333.
38. Angoulvant D, Fazel S, Li RK. Neovascularization derived from cell transplantation in ischemic myocardium. Mol Cell Biochem 2004;264:133-142.